Chris P Conlon FRCP
Professor of Infectious Diseases
- Head of NDM Experimental Medicine
- Member of congregation
- Group Head / PI
- Consultant Physician and Unit Director
I am responsible for a mixture of clinical, teaching, research and administrative duties, including covering the 18 bed Infectious Diseases Unit at the Churchill Hospital. I collaborate with colleagues in HIV research and am currently on the trial steering committee of the RIVER study; a proof of principle trial of HDAC inhibitors and HIV vaccine use in an attempt to ‘cure’ HIV. I also run the TB service in Oxford and collaborate with Professor Derrick Crook and others using whole genome sequencing to improve diagnoses. I also have oversight of the Tropical Medicine Group and was recently invited to lecture at The First Beijing International Conference on Precision Medicine and Cancer Treatment Forum with a talk entitled “Medical Education in the 21st Century”
I am a Fellow and Tutor in Clinical Medicine at Oriel College, Oxford and regularly teach Oxford medical undergraduates in lectures and seminars, and at the bedside. In addition, I am a Principal Examiner in Medicine in Oxford and Chair of the Royal College of Physicians Joint Specialty Committee for Infectious Diseases.
I was Interim Head of Department for the Nuffield Department of Medicine from May 2016 until June 2019. I have also been the Head NDM Experimental Medicine since 2014.
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Sampson O. et al, (2022), J Immunol Methods, 504
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
Eyre DW. et al, (2020), eLife, 9
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
Peng Y. et al, (2020)